Dan Klein - Healthcare Trust Executive Vice President - Business Development
| HTADelisted Stock | USD 26.67 0.25 0.95% |
President
Mr. Dan Klein is Executive Vice President Business Development of the Company. In this role Dan will help drive HTA investment activities with a primary responsibility for growing HTA strategic relationships with health systems academic medical centers universities with a healthcare focus physicians and regional developers since 2016.
| Tenure | 8 years |
| Phone | 480 991-0755 |
| Web | www.htareit.com |
Healthcare Trust Management Efficiency
The company has Return on Asset of 1.62 % which means that on every $100 spent on assets, it made $1.62 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 3.03 %, implying that it generated $3.03 on every 100 dollars invested. Healthcare Trust's management efficiency ratios could be used to measure how well Healthcare Trust manages its routine affairs as well as how well it operates its assets and liabilities.The company has 3.25 B in debt with debt to equity (D/E) ratio of 0.97, which is OK given its current industry classification. Healthcare Trust has a current ratio of 1.57, which is typical for the industry and considered as normal. Debt can assist Healthcare Trust until it has trouble settling it off, either with new capital or with free cash flow. So, Healthcare Trust's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Healthcare Trust sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Healthcare to invest in growth at high rates of return. When we think about Healthcare Trust's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Stuart MacFarlane | Anheuser Busch Inbev | 50 | |
| Jason Warner | Anheuser Busch Inbev | 48 | |
| Luiz Edmond | Anheuser Busch Inbev | 49 | |
| J Kirkland | Vector Group | 55 | |
| Carlos Lisboa | Anheuser Busch Inbev | 55 | |
| Airton Hentschke | Universal | 54 | |
| Graham Staley | Anheuser Busch Inbev | N/A | |
| Michel Doukeris | Anheuser Busch Inbev | 51 | |
| David Ballard | Vector Group | 56 | |
| Lori Beaudion | Duckhorn Portfolio | 60 | |
| Nicholas Anson | Vector Group | 51 | |
| James Huffman | Universal | 62 | |
| Preston Wigner | Universal | 55 | |
| Yasushi Shingai | Japan Tobacco ADR | 61 | |
| Joao Neves | Anheuser Busch Inbev | 49 | |
| Ricardo Tadeu | Anheuser Busch Inbev | 48 | |
| Robert Peebles | Universal | 60 | |
| Jean Neto | Anheuser Busch Inbev | 50 | |
| Akira Saeki | Japan Tobacco ADR | 54 | |
| Candace Formacek | Universal | 64 | |
| Ricardo Moreira | Anheuser Busch Inbev | 50 | |
Management Performance
| Return On Equity | 3.03 | |||
| Return On Asset | 1.62 |
Healthcare Trust Leadership Team
Elected by the shareholders, the Healthcare Trust's board of directors comprises two types of representatives: Healthcare Trust inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Healthcare. The board's role is to monitor Healthcare Trust's management team and ensure that shareholders' interests are well served. Healthcare Trust's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Healthcare Trust's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Foss, Interim President and Chief Executive Officer, Director | ||
| Dan Klein, Executive Vice President - Business Development | ||
| Vicki Booth, Independent Director | ||
| Daniel Henson, Independent Director | ||
| Roberta Bowman, Independent Director | ||
| Amanda Houghton, Executive Vice President - Asset Management | ||
| Warren Fix, Independent Director | ||
| Maurice DeWald, Independent Director | ||
| Robert Milligan, Chief Financial Officer, Treasurer, Company Secretary | ||
| Reshma Block, Independent Director | ||
| Constance Moore, Independent Director | ||
| H Cooper, Independent Director | ||
| Larry Mathis, Independent Director | ||
| Scott Peters, Chairman, CEO and President and Member of Investment Committee | ||
| Vicki Boot, Independent Director | ||
| Mark Engstrom, Executive VP of Acquisitions | ||
| Steve Patterson, Independent Director | ||
| W Blair, Lead Independent Director | ||
| Jay Leupp, Independent Director | ||
| Gary Wescombe, Independent Director | ||
| Kristen Armstrong, IR Contact Officer | ||
| Bradley Blair, Lead Independent Director |
Healthcare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Healthcare Trust a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 3.03 | |||
| Return On Asset | 1.62 | |||
| Profit Margin | 12.75 % | |||
| Operating Margin | 58.85 % | |||
| Current Valuation | 10.26 B | |||
| Shares Outstanding | 220.84 M | |||
| Shares Owned By Insiders | 0.29 % | |||
| Shares Owned By Institutions | 97.55 % | |||
| Number Of Shares Shorted | 8.69 M | |||
| Price To Earning | 58.38 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Healthcare Stock
If you are still planning to invest in Healthcare Trust check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Healthcare Trust's history and understand the potential risks before investing.
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |